Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study-Reference-Cited by-同舟云学术

Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study

Published:2019-03 Issue:2 Volume:2 Page:126-134
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Downer Mary K.,Allard Christopher B.,Preston Mark A.,Wilson Kathryn M.,Kenfield Stacey A.,Chan June M.,Mucci Lorelei A.,Giovannucci Edward,Stampfer Meir J.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference28 articles.

1. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials;Rothwell;Lancet,2011

2. Aspirin and cancer risk: a quantitative review to 2011;Bosetti;Ann Oncol,2012

3. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement;U.S. Preventive Services Task Force;Ann Intern Med,2009

4. Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis;Mahmud;Int J Cancer,2010

5. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis;Liu;BMC Med,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying modifiable risk factors to prevent aggressive colorectal cancer;International Journal of Cancer;2024-05-08

2. Effect of aspirin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from randomized controlled trials and real-world studies;European Journal of Clinical Pharmacology;2023-08-30

3. Seleno‐aspirin compound AS‐10 promotes histone acetylation ahead of suppressing androgen receptor transcription, G1 arrest, and apoptosis of prostate cancer cells;The Prostate;2022-08-22

4. Inflammation and Prostate Cancer: A Multidisciplinary Approach to Identifying Opportunities for Treatment and Prevention;Cancers;2022-03-08

5. Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer;Prostate Cancer and Prostatic Diseases;2022-01-24